CTRI Number |
CTRI/2017/09/009812 [Registered on: 18/09/2017] Trial Registered Prospectively |
Last Modified On: |
16/09/2017 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Yoga & Naturopathy |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
To study the effect of Yoga on glucose and mental health |
Scientific Title of Study
|
Effect of Yoga on psychological, cognitive and glycemic control in patients with T2DM and Depression: Two arm parallel Randomized controlled trial |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Yashdeep Gupta |
Designation |
Assistant Professor |
Affiliation |
All India Institute of Medical Sciences |
Address |
Room No 308, Endocrine office, 3rd Floor, Biotechnology building, AIIMS, Ansari Nagar, Delhi
New Delhi DELHI 110029 India |
Phone |
01126593645 |
Fax |
|
Email |
yash_deep_gupta@yahoo.co.in |
|
Details of Contact Person Scientific Query
|
Name |
Yashdeep Gupta |
Designation |
Assistant Professor |
Affiliation |
All India Institute of Medical Sciences |
Address |
Room No 308, Endocrine office, 3rd Floor, Biotechnology building, AIIMS, Ansari Nagar, Delhi
New Delhi DELHI 110029 India |
Phone |
01126593645 |
Fax |
|
Email |
yash_deep_gupta@yahoo.co.in |
|
Details of Contact Person Public Query
|
Name |
Yashdeep Gupta |
Designation |
Assistant Professor |
Affiliation |
All India Institute of Medical Sciences |
Address |
Room No 308, Endocrine office, 3rd Floor, Biotechnology building, AIIMS, Ansari Nagar, Delhi
New Delhi DELHI 110029 India |
Phone |
01126593645 |
Fax |
|
Email |
yash_deep_gupta@yahoo.co.in |
|
Source of Monetary or Material Support
|
Department of Science & Technology,
Technology Bhavan, New Mehrauli Road,,
New Delhi-110 016. |
|
Primary Sponsor
|
Name |
Applied for funding to Department of Science and Technology Delhi |
Address |
Applied for funding to Department of Science and Technology, Delhi |
Type of Sponsor |
Government funding agency |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
YASHDEEP GUPTA |
All India Institute of Medical Sciences, New Delhi |
Department of Endocrinology and Metabolism, Seminar Room, AB-6 ward, Ansari Nagar New Delhi DELHI |
01126593645
yash_deep_gupta@yahoo.co.in |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institute Ethics Committee, All India Institute of Medical Sciences, New Delhi |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
Diabetes with mild to moderate depression (PHQ 9 score from 5 to 14), |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Usual Care |
Diet and activity advice of 30 minutes |
Intervention |
Yoga for 45 minutes |
An integrated module has been made using specific Asanas, Kriyas, breathing exercises and meditation as to target depressive symptoms and glycemic control. The physical activity component of yoga module (Asanas/Kriyas) are designed separately for those who have no limitation to physical activity and for those who have such limitation. The yoga sessions will be given by trained certified yoga therapists supervised by Assistant Professor and Acharya from S-VYASA, Bengaluru. |
|
Inclusion Criteria
|
Age From |
30.00 Year(s) |
Age To |
80.00 Year(s) |
Gender |
Both |
Details |
1 Type 2 diabetes
2 Age > 30 years
3 Willing to come for Yoga sessions/study visits in AIIMS as per module
4 On basis of HbA1c depending upon type of therapy
a) ≥ 7.5% to ≤ 9% if only on oral drugs ± basal insulin
b) ≥ 7.5% to ≤ 10 %, if on premix insulin for ≥ 6 months, and glycemic status has not been successfully optimized despite on regular follow up of recruiting clinic for atleast 6 months and 4 clinical visits
c) ≥ 7.5% to any degree of hyperglycemia, if on multiple dose insulin for ≥ 6 months and glycemic status has not been successfully optimized, despite on regular follow up of recruiting clinic for atleast 6 months and 4 clinical visits
5 Eligibility on basis of patient health questionnaire-9 (PHQ-9)Patients with mild to moderate depression (PHQ-9 score from 5-14) are eligible. Details of PHQ-9 are given ahead.
|
|
ExclusionCriteria |
Details |
1 Terminal illness
2 Known case of cancer
3 Nephropathy with CKD stage 4 and 5
4 Severe Non proliferative diabetic retinopathy, proliferative diabetic retinopathy, or macular edema
5 Any cardiovascular event requiring hospitalization in last 6 months
6 Active diabetic foot ulcer
7 Hospitalization for more than 24 hours within one month or 2 such episodes in last 6 months
8 Any death of first degree relative in last 6 months
9 PHQ-9 score < 5 or > 14
10 Suicidal thoughts nearly everyday i.e score of 3 for question 9 of PHQ-9 questionnaire
11 Patients with dementia (Montreal cognitive assessment or MOCA score < 19
|
|
Method of Generating Random Sequence
|
Permuted block randomization, variable |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Outcome Assessor Blinded |
Primary Outcome
|
Outcome |
TimePoints |
To evaluate the effect of Yoga on depression in patients with T2DM |
At 4 months |
|
Secondary Outcome
|
Outcome |
TimePoints |
To evaluate the effect of Yoga on depression in patients with T2DM |
At 8 months |
To evaluate the effect of Yoga on anxiety in patients with T2DM |
At 4 and 8 months |
To evaluate the effect of Yoga on diabetes related distress in patients with T2DM |
At 4 and 8 months |
To evaluate the effect of Yoga on cognitive functions in patients with T2DM |
At 4 and 8 months |
To evaluate the effect of Yoga on glycemic control in patients with T2DM |
At 4 and 8 months |
To evaluate the effect of Yoga on other cardiovascular risk factors like weight, body mass index, blood pressure and lipid profile |
At 4 and 8 months |
|
Target Sample Size
|
Total Sample Size="320" Sample Size from India="320"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
01/01/2018 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
None yet |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
The study
will assess effect of yoga and meditation on depression, anxiety, diabetes
related distress, cognitive deficits, glycemic control and metabolic risk
factors in patients with Type 2 diabetes who have comorbid depression at
baseline. The study is a randomized controlled trial with parallel arm comparator
[prescription of 30 minutes of walking]. The study has been powered to 90% to
detect even 10% difference in depression scores between the two arms. The study
has a component of intervention phase of 4 months in which yoga will be taught
and supervised by Yoga therapists and a component of sustainability phase, in
which the patients will have no further supervised yoga sessions. Since, this
study is pragmatic in nature, we will see whether there is benefit of yoga on
multiple domains in diabetes after intervention phase. The aim of
sustainability phase will evaluate whether the effects can be sustained after
supervision is over. The end of 8 months evaluation will help in knowing the
medium term effects of yoga.
The
current study will do comprehensive assessment of cognitive deficits by
psychological tests. This sort of comprehensive work has never been done before
globally.
The
broader aim of this study is to have deeper understanding of yoga in Type
2 diabetes, and then subsequently try to see yoga as first choice or
alternative to physical activity for these patients, which may help in better
managing their diabetes, enhance their work related performance and
inter-personal interactions. |